LATEST NA-CLTM 2026/2027 TEST BANK
WITH ACTUAL EXAM QUESTIONS AND
CORRECT ANSWERS WITH DETAILED
RATIONALES GRADED A+
Q1. A patient with a history of refractory focal epilepsy is
started on an antiseizure medication (ASM) and returns to
the clinic two weeks later presenting with profound irritability
and aggressive behavior changes that are highly
uncharacteristic for them. Which of the following ASM
combinations represents the most likely causative agents?
A) Neurontin, Lamictal, and Topamax
B) Levetiracetam (Keppra), Zonegran, and Fycompa
C) Zarontin, Depakene, and Lyrica
D) Sabril, Gabitril, and Phenobarbital
• Correct Answer: B
• Rationale: Levetiracetam (Keppra), Zonegran, and
Fycompa are notorious for psychiatric adverse effects,
notably behavioral disturbances including irritability,
agitation, and aggression. Recognizing these side effects is
critical during long-term monitoring and drug adjustments.
Q2. A 24-year-old patient being monitored in the Epilepsy
Monitoring Unit (EMU) develops a high fever, diffuse mucosal
lesions, and a severe blistering skin rash covering
,approximately 25% of their body surface area. The patient
was recently started on Lamictal. This presentation is most
consistent with which life-threatening condition?
A) Acute Angle-Closure Glaucoma
B) Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis
(TEN)
C) Aplastic Anemia
D) Systemic Lupus Erythematosus flare-up
• Correct Answer: B
• Rationale: Stevens-Johnson Syndrome (SJS) and Toxic
Epidermal Necrolysis (TEN), also known as Lyell's
syndrome, are severe, life-threatening idiosyncratic
cutaneous adverse reactions characterized by sheet-like
epidermal necrosis and mucosal desquamation, frequently
triggered by aromatic ASMs like lamotrigine, phenytoin, and
carbamazepine.
Q3. A female patient of childbearing potential requires
monotherapy for newly diagnosed generalized epilepsy. To
minimize the risk of structural teratogenicity and major
congenital birth defects, which of the following pairs of ASMs
should be avoided as first-line monotherapy?
A) Gabapentin and Levetiracetam
B) Valproate and Topiramate
C) Ethosuximide and Lamotrigine
D) Lacosamide and Clobazam
• Correct Answer: B
, • Rationale: Valproate and topiramate monotherapies are
heavily associated with high rates of teratogenicity, including
neural tube defects, craniofacial abnormalities, and
neurodevelopmental delays, making them unfavorable
choices for young female patients when safer alternatives
exist.
Q4. During a clinical assessment in a long-term monitoring
unit, a patient on chronic high-dose ASM therapy exhibits
subtle hyperactivity, short-term memory deficits, decreased
concentration, and new-onset mild anxiety. These findings
are best categorized as:
A) Pathognomonic signs of an acute ischemic stroke
B) Common cognitive and behavioral side effects of ASM toxicity
or maintenance therapy
C) Structural evolution of Lennox-Gastaut Syndrome
D) Normal physiological adjustments to seizure freedom
• Correct Answer: B
• Rationale: ASMs exert profound effects on central nervous
system networks; common neurocognitive side effects
frequently encompass attention deficits, short-term memory
impairment, hyperactivity, mood alterations, and anxiety.
Q5. A neurodiagnostic specialist reviewing a patient's chart
notes that the managing epileptologist selected an ASM
specifically because it dual-functions to improve the patient's
comorbid depressive mood disorder. Which of the following
groups of ASMs possess recognized mood-stabilizing or
mood-improving properties?
, A) Sabril, Gabitril, and Phenobarbital
B) Neurontin, Lamictal, Topamax, and Depakote
C) Felbatol, Keppra, and Briviact
D) Zarontin, Mysoline, and Vigabatrin
• Correct Answer: B
• Rationale: Certain anti-seizure medications, particularly
lamotrigine (Lamictal), topiramate (Topamax), valproate
(Depakote), and gabapentin (Neurontin), exhibit positive
psychotropic profiles or mood-stabilizing properties that can
help manage comorbid mood dysregulation.
Q6. A patient being treated for focal dyscognitive seizures
reports a substantial worsening of depressive symptoms,
expressing deep lethargy and dysphoria since their last
medication change. Which of the following agents is most
closely linked to an increased risk of worsening depression?
A) Lamictal
B) Neurontin
C) Sabril
D) Depakote
• Correct Answer: C
• Rationale: Sabril (vigabatrin), along with Gabitril, Zonegran,
phenobarbital, mysoline, and Keppra, carries a heightened
clinical risk of inducing or exacerbating depressive
symptoms and suicidal ideation.
WITH ACTUAL EXAM QUESTIONS AND
CORRECT ANSWERS WITH DETAILED
RATIONALES GRADED A+
Q1. A patient with a history of refractory focal epilepsy is
started on an antiseizure medication (ASM) and returns to
the clinic two weeks later presenting with profound irritability
and aggressive behavior changes that are highly
uncharacteristic for them. Which of the following ASM
combinations represents the most likely causative agents?
A) Neurontin, Lamictal, and Topamax
B) Levetiracetam (Keppra), Zonegran, and Fycompa
C) Zarontin, Depakene, and Lyrica
D) Sabril, Gabitril, and Phenobarbital
• Correct Answer: B
• Rationale: Levetiracetam (Keppra), Zonegran, and
Fycompa are notorious for psychiatric adverse effects,
notably behavioral disturbances including irritability,
agitation, and aggression. Recognizing these side effects is
critical during long-term monitoring and drug adjustments.
Q2. A 24-year-old patient being monitored in the Epilepsy
Monitoring Unit (EMU) develops a high fever, diffuse mucosal
lesions, and a severe blistering skin rash covering
,approximately 25% of their body surface area. The patient
was recently started on Lamictal. This presentation is most
consistent with which life-threatening condition?
A) Acute Angle-Closure Glaucoma
B) Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis
(TEN)
C) Aplastic Anemia
D) Systemic Lupus Erythematosus flare-up
• Correct Answer: B
• Rationale: Stevens-Johnson Syndrome (SJS) and Toxic
Epidermal Necrolysis (TEN), also known as Lyell's
syndrome, are severe, life-threatening idiosyncratic
cutaneous adverse reactions characterized by sheet-like
epidermal necrosis and mucosal desquamation, frequently
triggered by aromatic ASMs like lamotrigine, phenytoin, and
carbamazepine.
Q3. A female patient of childbearing potential requires
monotherapy for newly diagnosed generalized epilepsy. To
minimize the risk of structural teratogenicity and major
congenital birth defects, which of the following pairs of ASMs
should be avoided as first-line monotherapy?
A) Gabapentin and Levetiracetam
B) Valproate and Topiramate
C) Ethosuximide and Lamotrigine
D) Lacosamide and Clobazam
• Correct Answer: B
, • Rationale: Valproate and topiramate monotherapies are
heavily associated with high rates of teratogenicity, including
neural tube defects, craniofacial abnormalities, and
neurodevelopmental delays, making them unfavorable
choices for young female patients when safer alternatives
exist.
Q4. During a clinical assessment in a long-term monitoring
unit, a patient on chronic high-dose ASM therapy exhibits
subtle hyperactivity, short-term memory deficits, decreased
concentration, and new-onset mild anxiety. These findings
are best categorized as:
A) Pathognomonic signs of an acute ischemic stroke
B) Common cognitive and behavioral side effects of ASM toxicity
or maintenance therapy
C) Structural evolution of Lennox-Gastaut Syndrome
D) Normal physiological adjustments to seizure freedom
• Correct Answer: B
• Rationale: ASMs exert profound effects on central nervous
system networks; common neurocognitive side effects
frequently encompass attention deficits, short-term memory
impairment, hyperactivity, mood alterations, and anxiety.
Q5. A neurodiagnostic specialist reviewing a patient's chart
notes that the managing epileptologist selected an ASM
specifically because it dual-functions to improve the patient's
comorbid depressive mood disorder. Which of the following
groups of ASMs possess recognized mood-stabilizing or
mood-improving properties?
, A) Sabril, Gabitril, and Phenobarbital
B) Neurontin, Lamictal, Topamax, and Depakote
C) Felbatol, Keppra, and Briviact
D) Zarontin, Mysoline, and Vigabatrin
• Correct Answer: B
• Rationale: Certain anti-seizure medications, particularly
lamotrigine (Lamictal), topiramate (Topamax), valproate
(Depakote), and gabapentin (Neurontin), exhibit positive
psychotropic profiles or mood-stabilizing properties that can
help manage comorbid mood dysregulation.
Q6. A patient being treated for focal dyscognitive seizures
reports a substantial worsening of depressive symptoms,
expressing deep lethargy and dysphoria since their last
medication change. Which of the following agents is most
closely linked to an increased risk of worsening depression?
A) Lamictal
B) Neurontin
C) Sabril
D) Depakote
• Correct Answer: C
• Rationale: Sabril (vigabatrin), along with Gabitril, Zonegran,
phenobarbital, mysoline, and Keppra, carries a heightened
clinical risk of inducing or exacerbating depressive
symptoms and suicidal ideation.
